Abstract
We investigated the first presence of qnrA among Shigella sonnei clinical isolates in Jiangsu Province, China. The qnrA-positive isolates coexisted with the mutation in gyrA at codon 83, these isolates were resistant to nalidixic acid and 22·2% (2 of 9) of them were resistant to norfloxacin.
Keywords:
Shigella sonnei; qnrA; China; fluoroquinolones.
MeSH terms
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Proteins / genetics*
-
China
-
Drug Resistance, Bacterial / genetics*
-
Nalidixic Acid / pharmacology*
-
Norfloxacin / pharmacology*
-
Shigella sonnei / drug effects*
-
Shigella sonnei / genetics
-
Shigella sonnei / isolation & purification
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Nalidixic Acid
-
Norfloxacin